A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we present a protocol to label platelet lysate-derived extracellular vesicles to monitor their migration and uptake in cartilage explants used as a model for osteoarthritis.
Extracellular vesicles (EVs) are used in different studies to prove their potential as a cell-free treatment due to their cargo derived from their cellular source, such as platelet lysate (PL). When used as treatment, EVs are expected to enter the target cells and effect a response from these. In this research, PL-derived EVs have been studied as a cell-free treatment for osteoarthritis (OA). Thus, a method was set up to label EVs and test their uptake on cartilage explants. PL-derived EVs are labeled with the lipophilic dye PKH26, washed twice through a column, and then tested in an in vitro inflammation-driven OA model for 5 h after particle quantification by nanoparticle tracking analysis (NTA). Hourly, cartilage explants are fixed, paraffined, cut into 6 µm sections to mount on slides, and observed under a confocal microscope. This allows verification of whether EVs enter the target cells (chondrocytes) during this period and analyze their direct effect.
Osteoarthritis (OA) is an articular degenerative disease that implies a progressive and irreversible inflammation and destruction of the extracellular matrix of the articular cartilage1. Although various forms of arthritis have numerous treatments2,3,4, these are restricted by their side effects and limited efficacy. Tissue engineering techniques using autologous chondrocyte implantation are routinely applied for the regenerative treatment of injured cartilage in early OA cartilage lesions4. Cell-based therapies are restricted m....
NOTE: Cartilage explants were obtained from the IdISBa Biobank (IB 1995/12 BIO) in compliance with institutional guidelines after ethical approval of the project by the CEI-IB (IB 3656118 PI).
1. Column preparation
A schematic overview for EV labeling and uptake monitoring is displayed in Figure 1. The particle concentration and EV size detected by NTA in Table 1 show that the EV concentration decreases during the process due to the purification step performed twice after labeling with the column. However, the amount obtained is in the optimal range of the number of particles to use for treatment. This particle concentration is used to calculate the volume of PKH-PL-EV and control that.......
EV imaging helps to understand EV properties, such as their release and uptake mechanisms. Their imaging allows the monitoring of their biodistribution and the characterization of their pharmacokinetic properties as drug vehicles. However, EV imaging and tracking may be difficult due to their small sizes, although many imaging devices and labeling techniques have been developed to help researchers monitor EVs under in vitro and in vivo conditions23,24.......
The authors have no conflicts of interest to disclose.
This research was funded by Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, co-funded by the ESF European Social Fund and the ERDF European Regional Development Fund (MS16/00124; CP16/00124); by the PROGRAMA JUNIOR del proyecto TALENT PLUS, construyendo SALUD, generando VALOR (JUNIOR01/18), financed by the sustainable tourism tax of the Balearic Islands; by the Direcció General d'Investigació, Conselleria d'Investigació, Govern Balear (FPI/2046/2017); by the FOLIUM postdoctoral program (FOLIUM 17/01) within the FUTURMed, financed at 50% by the sustainable tourism tax of the Balearic Islands and at 50% by the ESF; and....
Name | Company | Catalog Number | Comments |
Material | |||
1.5 mL Centrifuge tube | SPL life sciences | PLC60015 | |
1 mL Syringe BD Plastipak | BD | 303174 | |
2-Propanol (Isopropanol) | Panreac AppliChem | 1.310.901.211 | Prepared at 20% with Milli-Q water |
96-well culture plate | SPL life sciences | PLC30096 | |
Absolute ethanol Pharmpur | Scharlab | ET0006005P | Used to prepare 96% and 75% ethanol with Milli-Q water |
Biopsy Punch with plunger 3 mm | Scandidact | MTP-33-32 | |
Bovine serum Albumin (BSA) | Sigma-Aldrich | A7030 | Prepared at 5% with PBS |
Cartilage explants | IdISBa Biobank | ||
Concentrating tube 15 mL Nanosep 100 kD Omega | Pall | MCP100C41 | |
Concentrating tube 500 µL Nanosep 100 kD Omega | Pall | OD003C33 | |
Cover glass 24 x 60 mm | Deltalab | D102460 | |
DMEM-F12 -GlutaMAX medium | Biowest | L0092 | |
Dulbecco's PBS (1x) | Capricorn Scientific | PBS-1A | |
Embedded paraffin tissue blocks | IdISBa Biobank | Fee for service | |
Exo-spin mini-HD columns | Cell guidance systems | EX05 | |
Feather S35 Microtome Blade | Feather | 43037 | |
Filtropur S 0.2 µm syringe filter | Sarstedt | 83.1826.001 | |
Fluoroshield with DAPI | Sigma-Aldrich | F-6057 | |
Oncostatin M Human | Sigma-Aldrich | O9635-10UG | Prepare a stock solution to a final concentration of 0.1 µg/µL diluten in PBS-0.1% BSA |
Paraformaldehyde | Sigma-Aldrich | 8.18715.1000 | Prepared at 4% with PBS and stored at 4 °C |
Penicillin-Streptomycin Solution 100x | Biowest | L0022 | |
PKH26 Red Fluorescent Cell Linker Kit for General Cell Membrane Labeling | Sigma-Aldrich | MINI26 | PKH26 and Dliuent C included |
Sodium citrate dihydrate | Scharlab | SO019911000 | |
Superfrost Plus Microscope Slides | Thermo Scientific | J1800AMNZ | |
TNFα | R&D systems | 210-TA-005 | Prepare a stock solution to a final concentration of 0.01 µg/µL diluted in PBS-0.1% BSA |
Triton X-100 | Sigma-Aldrich | T8787 | Used to prepare a 0.1% Triton-0.1% sodium citrate solution with Milli-Q water |
Xylene | Scharlab | XI0050005P | |
Equipment | |||
Centrifuge 5430 R | Eppendorf | 5428000210 | F-45-48-11 rotor |
NanoSight NS300 | Malvern | NS300 | Device with embedded laser at λ= 532 nm and camera sCMOS |
Shandon Finesse 325 Manual Microtome | Thermo Scientific™ | A78100101 | |
TCS-SPE confocal microscope | Leica Microsystems | 5200000271 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved